- Home
- KALA vs CHNR Comparison
KALA vs CHNR Comparison
Compare KALA & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- CHNR
- Stock Information
- Founded
- KALA 2009
- CHNR N/A
- Country
- KALA United States
- CHNR China
- Employees
- KALA N/A
- CHNR N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- CHNR Precious Metals
- Sector
- KALA Health Care
- CHNR Basic Materials
- Exchange
- KALA Nasdaq
- CHNR Nasdaq
- Market Cap
- KALA 5.1M
- CHNR 4.7M
- IPO Year
- KALA 2017
- CHNR 1995
- Fundamental
- Price
- KALA $0.89
- CHNR $3.58
- Analyst Decision
- KALA Buy
- CHNR
- Analyst Count
- KALA 3
- CHNR 0
- Target Price
- KALA $31.50
- CHNR N/A
- AVG Volume (30 Days)
- KALA 1.6M
- CHNR 17.3K
- Earning Date
- KALA 11-19-2025
- CHNR 12-12-2025
- Dividend Yield
- KALA N/A
- CHNR N/A
- EPS Growth
- KALA N/A
- CHNR N/A
- EPS
- KALA N/A
- CHNR N/A
- Revenue
- KALA N/A
- CHNR N/A
- Revenue This Year
- KALA N/A
- CHNR N/A
- Revenue Next Year
- KALA N/A
- CHNR N/A
- P/E Ratio
- KALA N/A
- CHNR N/A
- Revenue Growth
- KALA N/A
- CHNR N/A
- 52 Week Low
- KALA $0.61
- CHNR $3.16
- 52 Week High
- KALA $20.60
- CHNR $8.20
- Technical
- Relative Strength Index (RSI)
- KALA 39.51
- CHNR 33.42
- Support Level
- KALA $0.61
- CHNR $3.21
- Resistance Level
- KALA $0.70
- CHNR $3.84
- Average True Range (ATR)
- KALA 0.09
- CHNR 0.26
- MACD
- KALA 0.25
- CHNR -0.03
- Stochastic Oscillator
- KALA 70.38
- CHNR 32.53
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.